Literature DB >> 9784560

SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis.

X Li1, J G Fox, M T Whary, L Yan, B Shames, Z Zhao.   

Abstract

Hepatitis, proliferative typhlitis, and colitis were characterized in young adult and older SCID/NCr mice naturally infected with Helicobacter hepaticus. Liver lesions consisted of Kupffer, Ito, and oval cell hyperplasia along with multifocal to coalescing coagulative hepatocyte necrosis. Numerous Warthin-Starry-positive bacteria were observed in the parenchyma, and there were minimal to mild accumulations of monocytic cells and neutrophils. Proliferative typhlitis was characterized by moderate to marked mucosal epithelial cell hyperplasia with mild monocytic and neutrophilic infiltration. Minimal to mild colitis with mucosal epithelial cell hyperplasia of the colon was most marked in older mice. Comparable gastrointestinal lesions were not observed in uninfected control SCID/NCr mice. H. hepaticus was cultured from fetal viscera of 2 of 11 pups sampled late in gestation from infected SCID/NCr females, suggesting transplacental infection of H. hepaticus. As expected, most of the naturally infected SCID/NCr mice had no serum immunoglobulin G response against H. hepaticus. These findings contrast with those in infected immunocompetent A/JCr mice, which develop a significant immune response to H. hepaticus associated with prominent multifocal mononuclear cell infiltrates in the liver, with only rare bacteria observable at the periphery of inflammatory foci or in the biliary canaliculi. The results demonstrate that chronic inflammatory and proliferative lesions simultaneously affecting the liver, cecum, and colon are associated with natural infection of SCID/NCr mice with H. hepaticus and that lesions are progressive with age. Concurrent infection with H. hepaticus may confound studies that have been attributed to similar lesions due to other experimental manipulations of SCID/NCr mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784560      PMCID: PMC108686     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Altering cytokine soups: a recipe for inflammatory bowel disease?

Authors:  J L Viney
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

2.  The biology of the SCID mutation.

Authors:  J D Ansell; G J Bancroft
Journal:  Immunol Today       Date:  1989-10

3.  Comparison of methods of identifying Helicobacter hepaticus in B6C3F1 mice used in a carcinogenesis bioassay.

Authors:  J G Fox; J A MacGregor; Z Shen; X Li; R Lewis; C A Dangler
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Experimental infection and abortion of pregnant guinea pigs with a unique spirillum-like bacterium isolated from aborted ovine fetuses.

Authors:  J H Bryner; A E Ritchie; L Pollet; C A Kirkbride; J E Collins
Journal:  Am J Vet Res       Date:  1987-01       Impact factor: 1.156

5.  Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa.

Authors:  G R Davies; N Banatvala; C E Collins; M T Sheaff; Y Abdi; L Clements; D S Rampton
Journal:  Scand J Gastroenterol       Date:  1994-05       Impact factor: 2.423

6.  Ultrastructural morphogenesis of 4-ipomeanol-induced bronchiolitis and interstitial pneumonia in calves.

Authors:  X Li; W L Castleman
Journal:  Vet Pathol       Date:  1990-05       Impact factor: 2.221

7.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.

Authors:  J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden
Journal:  J Natl Cancer Inst       Date:  1994-08-17       Impact factor: 13.506

9.  Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus.

Authors:  C J Foltz; J G Fox; R Cahill; J C Murphy; L Yan; B Shames; D B Schauer
Journal:  Helicobacter       Date:  1998-06       Impact factor: 5.753

10.  Interaction of lipopolysaccharides of Helicobacter pylori with basement membrane protein laminin.

Authors:  K H Valkonen; T Wadström; A P Moran
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more
  36 in total

1.  Ulcerative typhlocolitis associated with Helicobacter mastomyrinus in telomerase-deficient mice.

Authors:  K A Eaton; J S Opp; B M Gray; I L Bergin; V B Young
Journal:  Vet Pathol       Date:  2010-10-06       Impact factor: 2.221

2.  Lurking in the shadows: emerging rodent infectious diseases.

Authors:  David G Besselsen; Craig L Franklin; Robert S Livingston; Lela K Riley
Journal:  ILAR J       Date:  2008

3.  Citrobacter Infection and Wnt signaling.

Authors:  Shahid Umar
Journal:  Curr Colorectal Cancer Rep       Date:  2012-12

4.  Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice.

Authors:  Albert E Jergens; Jennifer H Wilson-Welder; Andrea Dorn; Abigail Henderson; Zhiping Liu; Richard B Evans; Jesse Hostetter; Michael J Wannemuehler
Journal:  Gut       Date:  2006-12-04       Impact factor: 23.059

5.  Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Authors:  Lillian Maggio-Price; Helle Bielefeldt-Ohmann; Piper Treuting; Brian M Iritani; Weiping Zeng; Andrea Nicks; Mark Tsang; Donna Shows; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 6.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

7.  Characterization of a Helicobacter hepaticus putA mutant strain in host colonization and oxidative stress.

Authors:  Navasona Krishnan; Alan R Doster; Gerald E Duhamel; Donald F Becker
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

8.  The use of cross-foster rederivation to eliminate murine norovirus, Helicobacter spp., and murine hepatitis virus from a mouse colony.

Authors:  James E Artwohl; Jeanette E Purcell; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-11       Impact factor: 1.232

9.  Prevalence of murine Helicobacter spp. Infection is reduced by restocking research colonies with Helicobacter-free mice.

Authors:  Jennifer Ls Lofgren; Michael Esmail; Melissa Mobley; Amanda McCabe; Nancy S Taylor; Zeli Shen; Susan Erdman; Christine Hewes; Mark T Whary; James G Fox
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-07       Impact factor: 1.232

10.  Detection of Helicobacter colonization of the murine lower bowel by genus-specific PCR-denaturing gradient gel electrophoresis.

Authors:  Martin Grehan; Gauri Tamotia; Bronwyn Robertson; Hazel Mitchell
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.